Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 PR Newswire WALTHAM, Mass., Oct. 14...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1199 | -3.48546511628 | 3.44 | 4.1499 | 3.21 | 469273 | 3.66669037 | CS |
| 4 | -1.0299 | -23.675862069 | 4.35 | 4.41 | 3.02 | 617875 | 3.49638137 | CS |
| 12 | -46.2799 | -93.30625 | 49.6 | 53.17 | 3.02 | 363261 | 10.49421371 | CS |
| 26 | -16.6699 | -83.3911955978 | 19.99 | 53.79 | 3.02 | 221223 | 18.63215184 | CS |
| 52 | -12.9199 | -79.5560344828 | 16.24 | 53.79 | 3.02 | 160622 | 19.12038424 | CS |
| 156 | -12.9199 | -79.5560344828 | 16.24 | 53.79 | 3.02 | 160622 | 19.12038424 | CS |
| 260 | -12.9199 | -79.5560344828 | 16.24 | 53.79 | 3.02 | 160622 | 19.12038424 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
